Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | MATURANA, MARIA |
| Género | Mujer |
| Área Principal WOS | Oncology; Medicine, General & Internal; Gastroenterology & Hepatology; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Oncology | 11 |
| Medicine, General & Internal | 1 |
| Gastroenterology & Hepatology | 1 |
| Scopus | #Pub |
|---|---|
| Oncology | 4 |
| Cancer Research | 4 |
| Medicine (All) | 1 |
| SciELO | #Pub |
|---|
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Jose Maturana, Maria | Pontificia Universidad Catolica de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| 2019 | Maturana, Maria J. | Pontificia Universidad Catolica de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| 2019 | Maturana, M. J. | Pontificia Universidad Catolica de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| 2019 | Maturana, Maria | Pontificia Universidad Catolica de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| 2019 | Maturana, Maria Jose | Pontificia Universidad Catolica de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Palabra Clave | #Pub |
|---|---|
| adenocarcinoma | 2 |
| prognosis | 2 |
| cancer subtypes | 2 |
| carcinoma | 2 |
| survival | 2 |
| epstein-barr-virus | 2 |
| gastric adenocarcinoma | 2 |
| gastric cancer | 2 |
| pd-l1 expression | 1 |
| inflammation | 1 |
| perspective quality-control | 1 |
| progression | 1 |
| risk | 1 |
| stomach | 1 |
| subtypes | 1 |
| suppresses | 1 |
| tff1 | 1 |
| tp53 | 1 |
| transcription factor | 1 |
| tumor mutational burden | 1 |
| tumor suppressor | 1 |
| molecular classification | 1 |
| molecular | 1 |
| mirna expression | 1 |
| 5-fluorouracil | 1 |
| immunotherapy | 1 |
| high-prevalence | 1 |
| helicobacter-pylori infection | 1 |
| gene | 1 |
| features | 1 |
| diffuse | 1 |
| chemotherapy | 1 |
| cell-proliferation | 1 |
| c-myc | 1 |
| breast-cancer | 1 |
| activation | 1 |